# Title

 Food and Drugs. PART 14—PUBLIC HEARING BEFORE A PUBLIC ADVISORY COMMITTEE


# ID

 CFR-2018-title21-vol1.Pt. 14


# Structured Analysis Summary

| Type        | Values                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|:------------|:-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Money       | [(128.8, 'USD'), (2500.0, 'USD')]                                                                                                                                                                                                                                                                                                                                                                                                                                |
| Constraints | ['least', 'first of', 'highest', 'before', 'within', 'prior to', 'more than', 'not to exceed', 'maximum', 'later than', 'less than', 'after', 'minimum', 'at least']                                                                                                                                                                                                                                                                                             |
| Duration    | ['30.0 day', '1.0 hour', '15.0 day', '2.0 year', '2.0 minute', '60.0 day', '3.0 week', '2.0 week', '90.0 day', '3.0 year', '4.0 day']                                                                                                                                                                                                                                                                                                                            |
| Condition   | ['until', 'unless', 'not subject to', 'where', 'as soon as', 'subject to', 'when', 'when not', 'if']                                                                                                                                                                                                                                                                                                                                                             |
| Entities    | ['United States', 'Written', 'Advice', 'Agency', 'Inquiry', 'Rockville, MD', 'Determination', 'Federal', 'Certification, Inspection', 'Washington', 'Freedom', 'Establishment', 'Scope', 'Food', 'Operations', 'Good', 'Applicability', 'Health', 'Public', 'Site', 'Voluminous', 'Rm', 'Information', 'Paragraph', 'Rockville']                                                                                                                                 |
| Date        | ['1992-06-26', '1990-10-27', '1988-10-28', '1968-10-18', '2015-10-06', '2061-05-01', '2004-06-18', '1980-05-13', '2009-08-12', '2012-04-25', '1973-06-02', '1990-01-22', '1978-09-01', '1897-03-02', '1984-07-09', '1979-12-31', '1970-08-27', '2011-05-18', '1980-10-07', '1972-02-17', '1974-04-05', '1978-03-03', '1991-08-27', '2064-05-01', '1975-07-01', '1993-07-06', '1978-03-23', '1978-05-01', '1987-05-17', '2009-07-09', '1978-05-31', '1974-06-04'] |


# Structured Analysis With Context

 


## Money

| Money           | Context                                                                                                                                            |
|:----------------|:---------------------------------------------------------------------------------------------------------------------------------------------------|
| (128.8, 'USD')  | The compensation of such costs includes personal compensation of committee members at a rate not to exceed $128.80 per member per day.             |
| (2500.0, 'USD') | (b) In the case of a request for referral to a color additive advisory committee, a special advance deposit is to be made in the amount of $2,500. |
| (2500.0, 'USD') | Where required, further advances in increments of $2,500 each are to be made upon request of the Commissioner.                                     |


## Constraints

| Constraints   | Context                                                                                                                                         |
|:--------------|:------------------------------------------------------------------------------------------------------------------------------------------------|
| before        | PART 14—PUBLIC HEARING BEFORE A PUBLIC ADVISORY COMMITTEE. before                                                                               |
| before        | to review and make recommendations on any matter before FDA and for interested persons to present information                                   |
| before        | to review and make recommendations on any matter before FDA and for interested persons to present information                                   |
| before        | chapter, a matter is subject to a hearing before  an advisory committee.                                                                        |
| before        | opportunity and instead under &#167;&#8201;12.32 requests a hearing before an advisory committee, and the Commissioner, as a                    |
| before        | scientific issues, which may relate to regulatory decisions before  FDA.                                                                        |
| before        | provide its views on a regulatory matter pending before  FDA.                                                                                   |
| before        | between the parties to a regulatory proceeding pending before FDA to review and prepare an initial decision                                     |
| before        | Purpose of proceedings  before  an advisory committee.                                                                                          |
| before        | public hearings on matters of importance that come before FDA, to review the issues involved, and to                                            |
| within        | past action, the person shall submit the petition within  30 days after the action objected to.                                                 |
| after         | person shall submit the petition within 30 days after  the action objected to.                                                                  |
| before        | make a reasonable effort to render a decision before  the action concerned in the petition.                                                     |
| minimum       | (b) The following  minimum standards apply to any committee of an independent                                                                   |
| after         | working under a contract initially executed with FDA after July 1, 1975, but which is determined not                                            |
| less than     | filed with the Division of Dockets Management not less than  15 days before the meeting.                                                        |
| before        | of Dockets Management not less than 15 days before  the meeting.                                                                                |
| after         | of Dockets Management and placed on public display. after                                                                                       |
| before        | Notice of hearing  before  an advisory committee.                                                                                               |
| before        | committee meetings to be held during the month. before                                                                                          |
| first of      | (a) Before the  first of each month, and at least 15 days in                                                                                    |
| at least      | (a) Before the first of each month, and  at least 15 days in advance of a meeting, the                                                          |
| after         | Any advisory committee meetings for that month called  after the publication of the general monthly notice are                                  |
| at least      | in the Federal Register on an individual basis at least  15 days in advance.                                                                    |
| less than     | a notice is published in the Federal Register less than 15 days before a meeting, an explanation for                                            |
| before        | in the Federal Register less than 15 days before a meeting, an explanation for the lateness of                                                  |
| before        | (c) If a public hearing  before an advisory committee is used in lieu of                                                                        |
| before        | procedure may be used for any other hearing before an advisory committee when the Commissioner concludes, as                                    |
| after         | If any matter is added to the agenda after its publication in the Federal Register under &#167;&#8201;14.20(b)(4),                              |
| before        | Any matter  before the advisory committee is to be decided by                                                                                   |
| least         | in government facilities or other facilities involving the least  expense to the public.                                                        |
| after         | is closed, the closed portion will be held after  the conclusion of the open portion whenever practicable.                                      |
| after         | during meetings and report and discuss committee deliberations after a meeting is completed and before official minutes                         |
| before        | committee deliberations after a meeting is completed and before official minutes or a report are available, within                              |
| within        | before official minutes or a report are available, within the rules and regulations adopted by FDA and                                          |
| before        | A committee discusses any matter pending  before it in an open portion of its meeting                                                           |
| maximum       | To the  maximum extent feasible, consistent with the policy expressed in                                                                        |
| before        | Deliberations about matters  before an advisory committee may be held in a                                                                      |
| within        | consultants, or other persons in a commercial arrangement within  the meaning of &#167;&#8201;20.81(a).                                         |
| within        | for consideration of existing internal agency documents falling within &#167;&#8201;20.62 where premature disclosure is likely to significantly |
| within        | for consideration of existing internal agency documents falling within &#167;&#8201;20.62 where premature disclosure is likely to significantly |
| before        | Conduct of a hearing  before  an advisory committee.                                                                                            |
| at least      | constitutes a public hearing under &#167;&#8201;14.25(a), will be at least 1 hour, unless public participation does not last                    |
| before        | other designated agency employee, orally or in writing, before  the meeting.                                                                    |
| before        | the time that the presentation is to begin. before                                                                                              |
| before        | with that member's permission and only about matters before  the committee.                                                                     |
| before        | information or views relevant to any matter pending before  the committee.                                                                      |
| before        | confer with specific persons about any matter pending before  the committee.                                                                    |
| before        | a specific product on which action is pending before FDA, and is being reviewed by an advisory                                                  |
| before        | pertinent information for review by the committee members before  the meeting, or both.                                                         |
| at least      | Designated Federal Officer or other designated agency employee at least  3 weeks before the meeting.                                            |
| before        | other designated agency employee at least 3 weeks before  the meeting.                                                                          |
| after         | and give public notice of, a cutoff date after which submissions about a matter will no longer                                                  |
| before        | review and make recommendations on any matter pending before  FDA.                                                                              |
| before        | Except for committees established by statute,  before a committee is established or renewed it must                                             |
| at least      | A notice of establishment will be published  at least 15 days before the filing of the advisory                                                 |
| before        | establishment will be published at least 15 days before the filing of the advisory committee charter under                                      |
| prior to      | though it is not established by the agency, prior to  utilization.                                                                              |
| later than    | when it is no longer needed, or not later than 2 years after its date of establishment unless                                                   |
| after         | longer needed, or not later than 2 years after its date of establishment unless it is renewed                                                   |
| before        | inadvertent references that occur are to be deleted before  public disclosure.                                                                  |
| at least      | is closed, the committee will issue a report at least annually setting forth a summary of its activities                                        |
| before        | Administrative record of a public hearing  before  an advisory committee.                                                                       |
| after         | The minutes of all portions of all meetings, after  any deletions under &#167;&#8201;14.60(b)(4).                                               |
| after         | minutes of any open portion of a meeting: after they have been approved by the committee and                                                    |
| after         | undue interference with agency or advisory committee operations. after                                                                          |
| after         | undue interference with agency or advisory committee operations. after                                                                          |
| after         | without undue interference with agency or committee operations. after                                                                           |
| after         | without undue interference with agency or committee operations. after                                                                           |
| before        | scientific expertise to handle the problems that come before it; and (ii) Except for members of the                                             |
| within        | a ballot to be filled out and returned within  30 days.                                                                                         |
| highest       | counted and the nominee who has received the highest number of votes will be selected as the                                                    |
| highest       | by lot from among those tied for the highest number of votes (5) If a member representing                                                       |
| before        | member representing consumer interests resigns or is removed before termination of the committee on which the member                            |
| after         | consumer organizations by telephone and elicit their votes. after                                                                               |
| highest       | The candidate who has received the  highest  number of votes will be selected.                                                                  |
| highest       | by lot from among those tied for the highest  number of votes.                                                                                  |
| within        | appoint a nonvoting member, a notice requesting that, within 30 days, any industry organization interested in participating                     |
| within        | responsibility to consult with each other in selecting, within 60 days after receipt of the letter, a                                           |
| after         | with each other in selecting, within 60 days after receipt of the letter, a single nonvoting member                                             |
| within        | If no individual is selected  within 60 days, the Commissioner will select the nonvoting                                                        |
| within        | or group, but rather represents all interested persons within the class which the member is selected to                                         |
| within        | Accordingly, an interested person  within the class represented by that nonvoting member may,                                                   |
| before        | If a matter comes  before the committee that directly or indirectly affects the                                                                 |
| within        | of business, or in an FDA facility located within the member's commuting area, and at a daily                                                   |
| within        | and technical issues as well as emerging issues within  the scientific community in industry and academia.                                      |
| before        | Cosmetic Act (21 U.S.C. 360kk(f)(1)(A)) to provide consultation before the Commissioner prescribes any performance standard for an              |
| after         | under 21 U.S.C. 360kk rests with the Commissioner, after  receiving the advice of TEPRSSC.                                                      |
| before        | product, or an amendment of an existing standard, before issuing a proposed regulation in the Federal Register                                  |
| at least      | meeting will be sent to members whenever possible at least  2 weeks before the meeting.                                                         |
| before        | to members whenever possible at least 2 weeks before  the meeting.                                                                              |
| at least      | (c) Ten members constitute a quorum, provided  at least three members are present from each group specified                                     |
| within        | any proposed performance standard for an electronic product within  60 days after consideration.                                                |
| after         | standard for an electronic product within 60 days after  consideration.                                                                         |
| after         | (a) The Commissioner will appoint the members  after consultation with public and private organizations concerned with                          |
| after         | (2) Five members selected from the affected industries  after  consultation with industry representatives.                                      |
| at least      | members selected from the general public, of whom at least  one shall be a representative of organized labor.                                   |
| before        | Will notify the Designated Federal Officer of TEPRSSC before any change in representative status on TEPRSSC which                               |
| before        | color additive on which important issues are pending before FDA and for interested persons to present information                               |
| before        | color additive on which important issues are pending before FDA and for interested persons to present information                               |
| before        | that requires scientific judgment and justifies a hearing before  a color additive advisory committee.                                          |
| before        | a color additive advisory committee at any time before , or within 30 days after, publication of                                                |
| within        | additive advisory committee at any time before, or within 30 days after, publication of an order of                                             |
| after         | at any time before, or within 30 days after , publication of an order of the Commissioner                                                       |
| after         | Within 60 days  after the first meeting, unless the time is extended                                                                            |
| within        | the report of the committee to the Commissioner within  90 days instead of 60 days.                                                             |
| more than     | handled concurrently by a color additive advisory committee. more than                                                                          |
| not to exceed | personal compensation of committee members at a rate not to exceed  $128.80 per member per day.                                                 |
| after         | Administration, 5600 Fishers Lane, Rockville, MD 20857, and after appropriate record of them is made, they will                                 |
| within        | regulatory control of the human prescription drugs falling within the pharmacologic class covered by the advisory committee                     |
| before        | particular matter involving a human prescription drug pending before FDA, including whether the available information is adequate               |
| within        | matter involving a human prescription drug under review within the agency may, in the discretion of the                                         |
| before        | upon the priorities of the various matters pending before the agency which fall within the pharmacologic class                                  |
| within        | various matters pending before the agency which fall within  the pharmacologic class covered by that committee.                                 |
| within        | matter involving a human prescription drug which falls within  the pharmacologic class covered by the committee.                                |
| after         | The Commissioner may,  after consulting with the committee on such request, grant                                                               |
| before        | of the priorities of the other matters pending before  the committee.                                                                           |


## Duration

| Duration   | Context                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
|:-----------|:-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 30.0 day   | (1) If the person objects to past action, the person shall submit the petition within 30 days after the action objected to.                                                                                                                                                                                                                                                                                                                                              |
| 15.0 day   | It is in any event to be filed with the Division of Dockets Management not less than 15 days before the meeting.                                                                                                                                                                                                                                                                                                                                                         |
| 2.0 minute | (2) Minutes of open sessions are to be maintained, with all written submissions attached which were made to the committee in open session.                                                                                                                                                                                                                                                                                                                               |
| 15.0 day   | (a) Before the first of each month, and at least 15 days in advance of a meeting, the Commissioner will publish a notice in the Federal Register of all advisory committee meetings to be held during the month.                                                                                                                                                                                                                                                         |
| 15.0 day   | Any advisory committee meetings for that month called after the publication of the general monthly notice are to be announced in the Federal Register on an individual basis at least 15 days in advance.                                                                                                                                                                                                                                                                |
| 15.0 day   | (6) The nature of the subjects to be discussed during, and the reasons for closing, any closed portion of the meeting;                                                                                                                                                                                                                                                                                                                                                   |
|            |               (7) The time set aside for oral statements and other public participation;                                                                                                                                                                                                                                                                                                                                                                                 |
|            |               (8) The name, address, and telephone number of the advisory committee Designated Federal Officer and any other agency employee designated as responsible for the administrative support for the advisory committee;                                                                                                                                                                                                                                        |
|            |               (9) A statement that written submissions may be made to the advisory committee through the Designated Federal Officer at any time, unless a cutoff date has been established under &#167;&#8201;14.35(d)(2);                                                                                                                                                                                                                                               |
|            |               (10) When a notice is published in the Federal Register less than 15 days before a meeting, an explanation for the lateness of the notice; and                                                                                                                                                                                                                                                                                                             |
| 1.0 hour   | (a) For each meeting, the open portion for public participation, which constitutes a public hearing under &#167;&#8201;14.25(a), will be at least 1 hour, unless public participation does not last that long, and may last for whatever longer time the committee Chairperson determines will facilitate the work of the committee.                                                                                                                                     |
| 3.0 week   | Unless specified otherwise, one copy of the written summary along with a proposed agenda outlining the topics to be covered and identifying the participating industry staff members or consultants that will present each topic is to be submitted to the Designated Federal Officer or other designated agency employee at least 3 weeks before the meeting.                                                                                                           |
| 15.0 day   | A notice of establishment will be published at least 15 days before the filing of the advisory committee charter under paragraph (c) of this section.                                                                                                                                                                                                                                                                                                                    |
| 15.0 day   | A notice of renewal does not require the 15-day notice.                                                                                                                                                                                                                                                                                                                                                                                                                  |
| 2.0 year   | (a) Except as provided in paragraph (c) of this section, a standing advisory committee is terminated when it is no longer needed, or not later than 2 years after its date of establishment unless it is renewed for an additional 2-year period.                                                                                                                                                                                                                        |
| 2.0 year   | (a) Except as provided in paragraph (c) of this section, a standing advisory committee is terminated when it is no longer needed, or not later than 2 years after its date of establishment unless it is renewed for an additional 2-year period.                                                                                                                                                                                                                        |
| 2.0 year   | A committee may be renewed for as many 2-year periods as the public interest requires.                                                                                                                                                                                                                                                                                                                                                                                   |
| 2.0 year   | (c) TEPRSSC is a permanent statutory advisory committee established by section 358(f)(1)(A) of the Public Health Service Act, as added by the Radiation Control for Health and Safety Act of 1968, transferred to the FD&amp;C Act (21 U.S.C. 360kk(f)(1)(A)), and is not subject to termination and renewal under paragraph (a) of this section, except that a new charter is prepared and filed at the end of each 2-year period as provided in &#167;&#8201;14.40(c). |
| 2.0 year   | Also, the statutory medical device classification panels established under section 513(b)(1) of the FD&amp;C Act (21 U.S.C. 360c(b)(1)) and part 860, and the statutory medical device good manufacturing practice advisory committees established under section 520(f)(3) of the FD&amp;C Act (21 U.S.C. 360j(f)(3)), are specifically exempted from the normal 2-year duration period.                                                                                 |
| 30.0 day   | (1) A period of 30 days will be permitted for submission of nominations for that committee or subcommittee.                                                                                                                                                                                                                                                                                                                                                              |
| 30.0 day   | Upon selection of the nominees to be placed on the ballot, the curriculum vitae for each of the nominees will be sent to each of the organizations on the list complied under paragraph (c)(3) of this section, together with a ballot to be filled out and returned within 30 days.                                                                                                                                                                                     |
| 4.0 day    | After 4 days have elapsed, the Advisory Committee Oversight and Management Staff will contact the consumer organizations by telephone and elicit their votes.                                                                                                                                                                                                                                                                                                            |
| 30.0 day   | (d) To select a nonvoting member to represent industry interests, the Commissioner will publish, for each committee for which the Commissioner has determined to appoint a nonvoting member, a notice requesting that, within 30 days, any industry organization interested in participating in the selection of an appropriate nonvoting member to represent industry interests send a letter stating that interest to the FDA employee designated in the notice.       |
| 30.0 day   | After 30 days, a letter will be sent to each organization that has expressed an interest, attaching a complete list of all such organizations, and stating that it is their responsibility to consult with each other in selecting, within 60 days after receipt of the letter, a single nonvoting member to represent industry interests for that committee.                                                                                                            |
| 60.0 day   | After 30 days, a letter will be sent to each organization that has expressed an interest, attaching a complete list of all such organizations, and stating that it is their responsibility to consult with each other in selecting, within 60 days after receipt of the letter, a single nonvoting member to represent industry interests for that committee.                                                                                                            |
| 60.0 day   | If no individual is selected within 60 days, the Commissioner will select the nonvoting member representing industry interests.                                                                                                                                                                                                                                                                                                                                          |
| 2.0 week   | (b) The agenda and other material to be considered at any meeting will be sent to members whenever possible at least 2 weeks before the meeting.                                                                                                                                                                                                                                                                                                                         |
| 60.0 day   | (d) The Chairperson of TEPRSSC will ordinarily submit a report to the Commissioner of the committee's consideration of any proposed performance standard for an electronic product within 60 days after consideration.                                                                                                                                                                                                                                                   |
| 30.0 day   | If the Chairperson believes that more time is needed, the Chairperson will inform the Director of the Center for Devices and Radiological Health in writing, in which case an additional 30 days will be allowed to make the report.                                                                                                                                                                                                                                     |
| 3.0 year   | (c) Appointments of members are for a term of 3 years or as specified by the Commissioner.                                                                                                                                                                                                                                                                                                                                                                               |
| 30.0 day   | (4) Any person adversely affected may request referral of the matter to a color additive advisory committee at any time before, or within 30 days after, publication of an order of the Commissioner acting upon a color additive petition or proposal.                                                                                                                                                                                                                  |
| 60.0 day   | Within 60 days after the first meeting, unless the time is extended as provided in paragraph (d) of this section, the Chairperson of the committee shall certify to the Commissioner the report containing the recommendations of the committee, including any minority report.                                                                                                                                                                                          |
| 90.0 day   | (d) If the Chairperson concludes that the color additive advisory committee needs additional time, the Chairperson shall so inform the Commissioner in writing and may certify the report of the committee to the Commissioner within 90 days instead of 60 days.                                                                                                                                                                                                        |
| 60.0 day   | (d) If the Chairperson concludes that the color additive advisory committee needs additional time, the Chairperson shall so inform the Commissioner in writing and may certify the report of the committee to the Commissioner within 90 days instead of 60 days.                                                                                                                                                                                                        |


## Condition

| Condition      | Context                                                                                                                                              |
|:---------------|:-----------------------------------------------------------------------------------------------------------------------------------------------------|
| when           | (a) This part governs the procedures  when  any of the following applies:                                                                            |
| subject to     | other sections of this chapter, a matter is subject to  a hearing before an advisory committee.                                                      |
| subject to     | advisory committee as defined in &#167;&#8201;10.3(a) and thus subject to this part and to the Federal advisory Committee                            |
| when           | An advisory committee includes any of its subgroups when the subgroup is working on behalf of the                                                    |
| when           | Section 14.40(d) describes  when a subgroup will be established as an advisory                                                                       |
| subject to     | advisory committee that is utilized by FDA is subject to this subpart even though it was not established                                             |
| when           | In general, a committee is utilized  when FDA requests advice or recommendations from the committee                                                  |
| when           | In general, a committee is utilized  when FDA requests advice or recommendations from the committee                                                  |
| if             | (i) A committee formed by an independent scient if ic or technical organization is utilized                                                          |
| if             | (i) A committee formed by an independent scient if ic or technical organization is utilized                                                          |
| if             | A committee formed by an independent scient if ic or technical organization is not utilized                                                          |
| if             | A committee formed by an independent scient if ic or technical organization is not utilized                                                          |
| subject to     | committee formed in response to the request are subject to substantial independent policy and factual review by the                                  |
| if             | (ii) A committee is not utilized by FDA  if it provides only information, as contrasted with advice                                                  |
| when           | (c) This part applies only  when  a committee convenes to conduct committee business.                                                                |
| subject to     | is utilized but not established by FDA is subject to this part only to the extent of such                                                            |
| subject to     | which is not an advisory committee shall be subject to &#167;&#8201;10.65 or other provisions specifically applicable to the                         |
| if             | and in accordance with the requirements of &#167;&#8201;10.30. if                                                                                    |
| if             | within 30 days after the action objected to. if                                                                                                      |
| if             | decision before the action concerned in the petition. if                                                                                             |
| if             | oral petition in lieu of a written petition. if                                                                                                      |
| if             | Health and Human Services under 45 CFR 5.34. if                                                                                                      |
| subject to     | under such a contract is an advisory committee subject to the Federal Advisory Committee Act and this subpart                                        |
| if             | the time of the open and closed portions; if                                                                                                         |
| unless         | through the Designated Federal Officer at any time, unless a cutoff date has been established under &#167;&#8201;14.35(d)(2);                        |
| when           | explanation for the lateness of the notice; and when                                                                                                 |
| if             | Register containing all the information described in &#167;&#8201;12.32(e). if                                                                       |
| when           | for any other hearing before an advisory committee when the Commissioner concludes, as a matter of discretion,                                       |
| if             | beginning of the open portion of the meeting. if                                                                                                     |
| unless         | DC, or Rockville, MD, or the immediate vicinity, unless the Commissioner receives and approves a written request                                     |
| when           | A different location may be approved  when one or more of the following applies: (1)                                                                 |
| unless         | committee, except as provided in &#167;&#8201;14.125(c) for TEPRSSC. unless                                                                          |
| if             | any advisory committee meeting which is not closed. if                                                                                               |
| where          | meeting to be held at a central location. where                                                                                                      |
| when           | will be closed by the committee Chairperson only when matters are to be discussed which the Commissioner                                             |
| if             | no reporting or discussion of any particular matter if  the committee or FDA spec                                                                    |
| where          | the committee or FDA specifically so directs, e.g., where deliberations are incomplete or involve a sensitive regulatory                             |
| unless         | a committee member have no status or effect unless adopted into the official minutes or report by                                                    |
| unless         | it in an open portion of its meeting unless the meeting has been closed for that matter                                                              |
| if             | However,  if information is in the form of a summary                                                                                                 |
| if             | portion of a meeting may be closed only if the Commissioner determines that the closing is permitted                                                 |
| if             | (3) Portions of meetings may ordinarily be closed  if they concern the review, discussion, and evaluation of                                         |
| if             | (3) Portions of meetings may ordinarily be closed  if they concern the review, discussion, and evaluation of                                         |
| if             | Portions of meetings ordinarily may not be closed if they concern review, discussion, and evaluation of general                                      |
| if             | instead be considered in a closed portion only if it is so inextricably intertwined with matters to                                                  |
| where          | of existing internal agency documents falling within &#167;&#8201;20.62 where premature disclosure is likely to significantly impede proposed        |
| if             | will be required to leave the meeting immediately. if                                                                                                |
| if             | is open to attendance by any interested person. if                                                                                                   |
| unless         | under &#167;&#8201;14.25(a), will be at least 1 hour, unless public participation does not last that long, and                                       |
| if             | the committee members in advance of the meeting if time permits, and otherwise will be distributed to                                                |
| when           | and otherwise will be distributed to the members when  they arrive for the meeting.                                                                  |
| unless         | or distribution may be undertaken only by FDA unless FDA grants permission to a person to mail                                                       |
| if             | Each person will be so informed in writing,  if  time permits, or by telephone.                                                                      |
| subject to     | for inclusion in the record of the hearing, subject to  the requirements of &#167;&#8201;14.35(c).                                                   |
| if             | a person is absent at the time spec if ied for that person's presentation, the persons following                                                     |
| when           | The Chairperson may allot additional time  when it is in the public interest, but may                                                                |
| if             | the authority to adjourn a hearing or meeting if the Chairperson determines that adjournment is in the                                               |
| if             | employee who is assigned to the advisory committee. if                                                                                               |
| if             | also authorized to adjourn a hearing or meeting if the employee determines adjournment to be in the                                                  |
| if             | at the closed portions of a meeting only if appointed as a special Government employee by the                                                        |
| unless         | at any portion of an advisory committee meeting unless they are appointed as special Government employees by                                         |
| when           | principal provisions; (e) Instructions on whom to contact when questions arise; and (f) Other material relating to                                   |
| unless         | to be sent to the Designated Federal Officer unless an applicable Federal Register notice or other regulations                                       |
| subject to     | Submissions are  subject to the provisions of &#167;&#8201;10.20, except that it is                                                                  |
| when           | be included in the minutes of the meeting when adopted and in the materials compiled under &#167;&#8201;14.33                                        |
| when           | it to the list of standing advisory committees. when                                                                                                 |
| if             | Commissioner will issue a Federal Register notice cert if ying that the establishment or renewal is in                                               |
| until          | (c) No committee may meet or take action  until its charter is prepared and filed as required                                                        |
| when           | subgroup will be established as a separate committee when the charter of the parent committee does not                                               |
| when           | subgroup will be established as a separate committee when the charter of the parent committee does not                                               |
| if             | by law will be established or utilized only if  it is in the public interest and only                                                                |
| if             | by law will be established or utilized only if  it is in the public interest and only                                                                |
| unless         | Federal Officer is responsible for all staff support unless  other agency employees are designated for this function.                                |
| when           | this section, a standing advisory committee is terminated when it is no longer needed, or not later                                                  |
| unless         | than 2 years after its date of establishment unless  it is renewed for an additional 2-year period.                                                  |
| if             | announcing the reasons for terminating a committee and, if it is a standing committee, amending &#167;&#8201;14.100 to                               |
| not subject to | the FD&amp;C Act (21 U.S.C. 360kk(f)(1)(A)), and is not subject to termination and renewal under paragraph (a) of this                               |
| subject to     | A color additive advisory committee is  subject to the termination and renewal requirements of the Federal                                           |
| not subject to | (21 U.S.C. 387q) (Pub. L. 111-31) and is not subject to termination and renewal under paragraph (a) of this                                          |
| if             | available for public disclosure under &#167;&#8201;14.75(a)(6)(i), or (2) if under &#167;&#8201;14.75(a)(6)(ii) they are not promptly available, the |
| where          | to the public consistent with 5 U.S.C. 552(b). where                                                                                                 |
| where          | at actual cost of duplication, which will be, where  applicable, the fees established in &#167;&#8201;20.45.                                         |
| as soon as     | recording of any open portion of a meeting: as soon as  it is available.                                                                             |
| as soon as     | closed portion of a meeting prepared under &#167;&#8201;14.60(c): as soon as  it is available.                                                       |
| as soon as     | committee at an open portion of a meeting: as soon as  they are submitted.                                                                           |
| subject to     | (2) Are  subject to the conflict of interest laws and regulations either                                                                             |
| subject to     | Electronic Product Radiation Safety Standards Committee (TEPRSSC), are subject to the conflict of interest laws and regulations either               |
| when           | (2) The Commissioner shall,  when  required by statute, and may                                                                                      |
| when not       | Commissioner shall, when required by statute, and may when not required by statute, provide for nonvoting members of                                 |
| subject to     | requirement; and (ii) May be special Government employees subject to the conflict of interest laws and regulations, except                           |
| unless         | nonvoting member on only one FDA advisory committee unless the Commissioner determines in writing that dual membership                               |
| until          | serve for the duration of the committee, or until their terms of appointment expire, they resign, or                                                 |
| when           | (a) This section applies  when the Commissioner concludes that a technical advisory committee                                                        |
| when           | (b) Except  when the Commissioner concludes otherwise, nonvoting members of a                                                                        |
| if             | serve out the term of the former member: if                                                                                                          |
| if             | the original ballot is willing to serve, or if there was only one nominee on the original                                                            |
| if             | the original ballot is willing to serve, or if there was only one nominee on the original                                                            |
| if             | or financial information as defined in &#167;&#8201;20.61 only if the person has been appointed as a special                                         |
| subject to     | A nonvoting member of an advisory committee is subject to , and shall abide by, all rules and                                                        |
| unless         | expenses, including per diem in lieu of subsistence, unless  such compensation and reimbursement are waived.                                         |
| unless         | expenses, including per diem in lieu of subsistence, unless  such compensation and reimbursement are waived.                                         |
| when           | assignment will be paid at an hourly rate when doing assigned work at home, a place of                                                               |
| when           | assignment will be paid at an hourly rate when doing assigned work at home, a place of                                                               |
| when           | (d) Salary while in travel status is authorized  when a committee member's ordinary pursuits are interrupted for                                     |
| if             | This applies on weekends and holidays  if the special Government employee loses income that would                                                    |
| when           | relevant information to aid TEPRSSC in its deliberations. when                                                                                       |
| where          | Sections 14.1 through 14.7 apply to TEPRSSC, except where other provisions are specifically included in &#167;&#167;&#8201;14.120 through            |
| if             | (d) A person otherwise qual if ied for membership is not eligible for selection                                                                      |
| when           | (b) All proceedings of TEPRSSC are open except  when the Commissioner has determined, under &#167;&#8201;14.27, that a                               |
| if             | The Commissioner may deny any petition  if inadequate grounds are stated for establishing a color                                                    |
| unless         | Within 60 days after the first meeting,  unless the time is extended as provided in paragraph                                                        |
| if             | inform the Commissioner in writing and may cert if y the report of the committee to the                                                              |
| subject to     | (a) A color additive advisory committee is  subject to all the requirements of the Federal Advisory Committee                                        |
| if             | establish a new advisory committee under this subpart. if                                                                                            |
| if             | color additive advisory committee from among experts qual if ied in the subject matter to be reviewed                                                |
| if             | advisory committee, the Commissioner will select the members. if                                                                                     |
| if             | under any other procedure that is mutually agreeable. if                                                                                             |
| subject to     | Members of a color additive advisory committee are subject to the requirements of the Federal Advisory Committee Act                                 |
| subject to     | Members of a color additive advisory committee are subject to the requirements of the Federal Advisory Committee Act                                 |
| when           | the basis of actual cost to the government. when                                                                                                     |
| when           | refund such fees in whole or in part when , in the Commissioner's judgment, such action will                                                         |
| subject to     | scientific or public controversy, or which may be subject to special regulatory requirements such as a limitation on                                 |
| subject to     | scientific or public controversy, or which may be subject to important regulatory actions such as withdrawal of approval                             |
| unless         | the matter will be made in open session unless it relates to an IND the existence of                                                                 |


## Entities

| Entities                  | Context                                                                                                                                           |
|:--------------------------|:--------------------------------------------------------------------------------------------------------------------------------------------------|
| Food                      | Food  and Drugs.                                                                                                                                  |
| Scope                     | Scope .                                                                                                                                           |
| Inquiry                   | (8) A Public Board of  Inquiry established under part 13, or other similar group                                                                  |
| Site                      | Site visits, social gatherings, informal discussions by telephone or                                                                              |
| Inquiry                   | example, part 13 for a Public Board of Inquiry .                                                                                                  |
| Health                    | with the procedures established by the Department of Health  and Human Services under 45 CFR 5.34.                                                |
| Applicability             | Applicability  to Congress.                                                                                                                       |
| Washington                | All advisory committee meetings will be held in  Washington , DC, or Rockville, MD, or the immediate                                              |
| Rockville                 | meetings will be held in Washington, DC, or Rockville , MD, or the immediate vicinity, unless the                                                 |
| Washington                | be provided in a conference room located in Washington , DC, or Rockville, MD, or the immediate                                                   |
| Rockville                 | a conference room located in Washington, DC, or Rockville , MD, or the immediate vicinity, to permit                                              |
| Determination             | Determination  to close portions of advisory committee meetings.                                                                                  |
| Written                   | Written  submissions to an advisory committee.                                                                                                    |
| Voluminous                | Voluminous  data is to be accompanied by a summary.                                                                                               |
| Establishment             | Establishment  and renewal of advisory committees.                                                                                                |
| Public                    | Public  inquiries and requests for advisory committee records.                                                                                    |
| Rm                        | 32,  Rm .                                                                                                                                         |
| Freedom                   | are to be made, to FDA's Division of Freedom  of Information  (the                                                                                |
| Information               | be made, to FDA's Division of Freedom of Information   (the Freedom of                                                                            |
| Health                    | delegation of authority, by the Assistant Secretary for Health , or the Commissioner.                                                             |
| Good                      | Good cause includes excessive absenteeism from committee meetings, a                                                                              |
| Federal                   | interest, consumer advocacy groups, and consumer/health branches of Federal , State, and local governments.                                       |
| Washington                | paid whether the meetings are held in the Washington , DC, area or elsewhere.                                                                     |
| United States             | for consumption of all tea imported into the United States  under 21 U.S.C. 42.                                                                   |
| Food                      | advice, information, and recommendations to the Commissioner of Food  and Drugs.                                                                  |
| Health                    | committee may provide recommendations to the Secretary of Health and Human Services regarding any regulations to be                               |
| Food                      | and makes appropriate recommendations to the Commissioner of Food  and Drugs.                                                                     |
| Food                      | as required, any other product for which the Food and Drug Administration has regulatory responsibility, and make                                 |
| Food                      | under sections 503A and 503B of the Federal Food , Drug, and Cosmetic Act and, as required,                                                       |
| Agency                    | Agency guidance and policies, clinical trial or registry design,                                                                                  |
| Food                      | research program that will assist the Commissioner of Food  and Drugs to fulfill regulatory responsibilities.                                     |
| United States             | are not full-time officers or employees of the United States receive compensation under &#167;&#8201;14.95, in accordance with 42                 |
| Paragraph                 | (1)  Paragraph (b) does not apply to any issue arising                                                                                            |
| Washington                | Food and Drug Administration, collectible at par in Washington , DC.                                                                              |
| Operations                | forwarded to the Associate Commissioner for Management and Operations , Food and Drug Administration, 5600 Fishers Lane,                          |
| Rockville, MD             | Operations, Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857, and after appropriate record of them is                         |
| United States             | will be transmitted to the Treasurer of the United States for deposit in the special account &#8220;Salaries and                                  |
| Certification, Inspection | deposit in the special account &#8220;Salaries and Expenses, Certification, Inspection , and Other Services, Food and Drug Administration.&#8221; |
| Advice                    | Advice  and recommendations in writing.                                                                                                           |
| Advice                    | Advice and recommendations given by a committee on a                                                                                              |


## Date

| Date       | Context                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|:-----------|:----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 1975-07-01 | (b) The following minimum standards apply to any committee of an independent scientific or technical organization which is working under a contract initially executed with FDA after July 1, 1975, but which is determined not to be an advisory committee:                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| 2061-05-01 | (c) Attendance at a closed portion of a meeting is governed by the following rules:                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
|            |               (1) A portion of a meeting closed for the presentation or discussion of information that constitutes a trade secret or confidential commercial or financial information as defined in &#167;&#8201;20.61 may be attended only by voting advisory committee members, nonvoting members representing consumer interests who are also special government employees as provided in &#167;&#8201;14.80(b), the Designated Federal Officer of the advisory committee, a transcriber, consultants, and such other regular employees of FDA (including members of the Office of the Chief Counsel) as the Chairperson of the advisory committee may invite, and by those persons authorized to be present under &#167;&#8201;14.25(c), for presentation of information prohibited from public disclosure. |
| 2064-05-01 | (2) A portion of a meeting that has been closed for consideration of existing internal agency documents falling within &#167;&#8201;20.62 where premature disclosure is likely to significantly impede proposed agency action; personnel, medical, and similar files, disclosure of which would be a clearly unwarranted invasion of personal privacy within the meaning of &#167;&#8201;20.63; or investigatory records compiled for law enforcement purposes as defined in &#167;&#8201;20.64 may be attended only by committee members (voting and nonvoting), the Designated Federal Officer of the committee, a transcriber, and other regular employees of FDA (including members of the Office of the Chief Counsel) whom the Chairperson of the committee may invite.                                   |
| 1897-03-02 | (i) Date established: March 2, 1897.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| 1992-06-26 | (i) Date established: June 26, 1992.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| 2004-06-18 | (i) Date established: June 18, 2004.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| 2009-07-09 | (i) Date rechartered: July 9, 2009.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| 2009-08-12 | (i) Date Established: August 12, 2009.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| 1984-07-09 | (i) Date established: July 9, 1984.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| 1988-10-28 | (i) Date established: October 28, 1988.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| 1980-05-13 | (i) Date established: May 13, 1980.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| 1979-12-31 | (4) Vaccines and Related Biological Products Advisory Committee&#8212;                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
|            |               (i) Date established: December 31, 1979.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| 1978-05-01 | (i) Date established: May 1, 1978.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| 1980-10-07 | (i) Date established: October 7, 1980.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| 1974-04-05 | (i) Date established: April 5, 1974.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| 1970-08-27 | (i) Date established: August 27, 1970.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| 1980-10-07 | (i) Date established: October 7, 1980.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| 1978-05-31 | (i) Date established: May 31, 1978.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| 1970-08-27 | (i) Date established: August 27, 1970.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| 1978-03-23 | (i) Date established: March 23, 1978.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| 1978-03-03 | (i) Date established: March 3, 1978.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| 1978-09-01 | (i) Date established: September 1, 1978.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| 1974-06-04 | (i) Date established: June 4, 1974.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| 1974-06-04 | (i) Date established: June 4, 1974.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| 1972-02-17 | (i) Date established: February 17, 1972.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| 2011-05-18 | (i) Date established: May 18, 2011.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| 1990-01-22 | (i) Date established: January 22, 1990.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| 1991-08-27 | (i) Date established: August 27, 1991.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| 2012-04-25 | (i) Date re-established: April 25, 2012.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| 1990-10-27 | (i) Date established: October 27, 1990.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| 1987-05-17 | (i) Date established: May 17, 1987.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| 1968-10-18 | (i) Date established: October 18, 1968.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| 1993-07-06 | (i) Date established: July 6, 1993.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| 2015-10-06 | (i) Date Established: October 6, 2015.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| 1973-06-02 | (1) Date established: June 2, 1973.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |


